Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2806)
All Articles published online
|
Apr 28, 2005 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yin XY, Lü MD, Liang LJ, Lai JM, Li DM, Kuang M. Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma. World J Gastroenterol 2005; 11(16): 2526-2529 [PMID: 15832431 DOI: 10.3748/wjg.v11.i16.2526] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i16/2526.htm |
| Number | Citing Articles |
| 1 |
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Immunotherapy of hepatocellular carcinoma. Journal of Hepatology 2006; 45(6): 868 doi: 10.1016/j.jhep.2006.09.004
|
| 2 |
Qi-Da Hu, Wei Chen, Tian-Lian Yan, Tao Ma, Cong-Lin Chen, Chao Liang, Qi Zhang, Xue-Feng Xia, Hao Liu, Xiao Zhi, Xiao-Xiao Zheng, Xue-Li Bai, Xia-Zhen Yu, Ting-Bo Liang. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial–mesenchymal transition in hepatocellular carcinoma cells. Cancer Letters 2012; 325(2): 207 doi: 10.1016/j.canlet.2012.07.003
|
| 3 |
Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Yasushi Uemura, Tetsuya Nakatsura. Potentiality of immunotherapy against hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(36): 10314-10326 doi: 10.3748/wjg.v21.i36.10314
|
| 4 |
Li‐Jian Liang, Wen‐Jie Hu, Xiao‐Yu Yin, Qi Zhou, Bao‐Gang Peng, Dong‐Ming Li, Ming‐De Lu. Adjuvant Intraportal Venous Chemotherapy for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombi Following Hepatectomy Plus Portal Thrombectomy. World Journal of Surgery 2008; 32(4): 627 doi: 10.1007/s00268-007-9364-0
|
| 5 |
Terry Lichtor, Alessandra Spagnolo, Roberta P. Glick, Douglas L. Feinstein, Dipak Panigrahy. PPAR‐γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors. PPAR Research 2008; 2008(1) doi: 10.1155/2008/547470
|
| 6 |
Ahmed O. Kaseb, Junichi Shindoh, Yehuda Z. Patt, Robert E. Roses, Giuseppe Zimmitti, Richard D. Lozano, Manal M. Hassan, Hesham M. Hassabo, Steven A. Curley, Thomas A. Aloia, James L. Abbruzzese, Jean‐Nicolas Vauthey. Modified cisplatin/interferon α‐2b/doxorubicin/5‐fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. Cancer 2013; 119(18): 3334 doi: 10.1002/cncr.28209
|
| 7 |
Zhang Chunhu, Hu Suiyu, Cao Meiqun, Xiao Guilin, Li Yunhui. Antiproliferative and apoptotic effects of paeonol on human hepatocellular carcinoma cells. Anti-Cancer Drugs 2008; 19(4): 401 doi: 10.1097/CAD.0b013e3282f7f4eb
|
| 8 |
Qiang Gao, Yinghong Shi, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Jia Fan. Translational medicine in hepatocellular carcinoma. Frontiers of Medicine 2012; 6(2): 122 doi: 10.1007/s11684-012-0193-7
|
| 9 |
Bazarragchaa Damdinsuren, Hiroaki Nagano, Morito Monden. Combined intra‐arterial 5‐fluorouracil and subcutaneous interferon‐alpha therapy for highly advanced hepatocellular carcinoma. Hepatology Research 2007; 37(s2) doi: 10.1111/j.1872-034X.2007.00191.x
|
| 10 |
Alessandra Spagnolo, Roberta P. Glick, Henry Lin, Edward P. Cohen, Douglas L. Feinstein, Terry Lichtor. Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor–γ thiazolidinedione agonists and interleukin-2–secreting syngeneic/allogeneic fibroblasts. Journal of Neurosurgery 2007; 106(2): 299 doi: 10.3171/jns.2007.106.2.299
|